Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Aug;81(16):5219-22.
doi: 10.1073/pnas.81.16.5219.

Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon

Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon

T W Chang et al. Proc Natl Acad Sci U S A. 1984 Aug.

Abstract

Mouse monoclonal antibodies B1 and B3 are specific for natural and Escherichia coli-derived recombinant human gamma-interferon (IFN-gamma). The two antibodies recognize different epitopes of the IFN-gamma molecule and do not compete with each other's binding. We have used these two antibodies to construct a solid-phase, sandwich immunoradiometric assay for human IFN-gamma. Purified antibody B1 was coated on polystyrene beads (0.64 cm in diameter) and used as the solid-phase immunoadsorbent and antibody B3 was labeled with 125I and used as tracer. This assay can be completed in about 4 hr and is capable of detecting IFN-gamma levels in human serum or tissue culture fluids as low as 0.1 NIH reference unit/ml. Recombinant human IFN-gamma derived from E. coli was detectable at a concentration of 0.02 ng/ml. The assay appears to be specific for the biologically active forms of IFN-gamma, since after exposure to pH 2, 37 degrees C, or 56 degrees C, biological activity and reactivity in the immunoradiometric assay decreased in parallel. The immunoradiometric assay can be employed for the analysis of the structural characteristics of the human IFN-gamma molecule.

PubMed Disclaimer

References

    1. J Immunol Methods. 1977;17(3-4):309-17 - PubMed
    1. J Immunol. 1982 Sep;129(3):934-5 - PubMed
    1. J Immunol. 1983 Apr;130(4):1683-6 - PubMed
    1. Science. 1982 Jan 22;215(4531):411-3 - PubMed
    1. J Immunol. 1983 Apr;130(4):1492-4 - PubMed

LinkOut - more resources